Evidence map›Paper›PMID 24862282›Full record

ArticleJournal of molecular biology2014

Glycan specificity of the Vibrio vulnificus hemolysin lectin outlines evolutionary history of membrane targeting by a toxin family.

Katherine Kaus, Jeffrey W Lary, James L Cole, Rich Olson

Abstract read
In one paragraph

Article in Journal of molecular biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.2field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Article
  3. Public health aspects ofEFSA journal. European Food Safety Authority · 2024
    Article
  4. Article
  5. Review
  6. Genetic and structural basis of the human anti-α-galactosyl antibody response.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  7. Review
  8. Bacterial pore-forming toxins.Microbiology (Reading, England) · 2022
    Article
  9. Review
  10. Review
  11. Article
  12. Frontiers in immunology · 2020
    Review
  13. Article
  14. Article
  15. Biochemistry and biophysics reports · 2016
    Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Katherine KausDepartment of Molecular Biology and Biochemistry, Wesleyan University, 52 Lawn Avenue, Middletown, CT 06459, USA.
Jeffrey W LaryBiotechnology-Bioservices Center, University of Connecticut, Storrs, CT 06269, USA.
James L ColeBiotechnology-Bioservices Center, University of Connecticut, Storrs, CT 06269, USA; Department of Molecular and Cell Biology and Department of Chemistry, University of Connecticut, Storrs, CT 06269, USA.
Rich OlsonDepartment of Molecular Biology and Biochemistry, Wesleyan University, 52 Lawn Avenue, Middletown, CT 06459, USA. Electronic address: rolson@wesleyan.edu.
University of Connecticut · USWesleyan University · US

Funding

X-RAY STRUCTURE OF RIFM PROTEIN FROM THE BIOSYNTHESIS PATHWAY OF THE ANSAMYCIN AP41RR012408 · NCRR · BROOKHAVEN SCIENCE ASSOC-BROOKHAVEN LAB · PI ORVILLE, ALLEN M · 1998 to 2011
$32.2M
Life Science and Biomedical technology Research center at NSLS-II LSBRP41GM111244 · NIGMS · BROOKHAVEN SCIENCE ASSOC-BROOKHAVEN LAB · PI MCSWEENEY, SEAN · 2014 to 2018
$16.4M
Macromolecular Crystallography at the National Synchrotron Light SourceP41GM103473 · NIGMS · BROOKHAVEN SCIENCE ASSOC-BROOKHAVEN LAB · PI SWEET, ROBERT M · 2012 to 2013
$4.9M
Protein-Glycan Interaction Resource of the CFGR24GM098791 · NIGMS · EMORY UNIVERSITY · PI CUMMINGS, RICHARD D, PAULSON, JAMES C · 2011 to 2013
$2.6M
DOCTORAL STUDIES IN MOLECULAR BIOPHYSICST32GM008271 · NIGMS · WESLEYAN UNIVERSITY · PI BEVERIDGE, DAVID LEWIS · 1988 to 2015
$1.8M
Mechanism of Cell Membrane Targeting by Vibrio Cholerae CytolysinR15AI101977 · NIAID · WESLEYAN UNIVERSITY · PI OLSON, RICHARD A · 2012 to 2012
$460k
NCRR NIH HHS P41 RR012408NCRR NIH HHS P41RR012408NIAID NIH HHS R15 AI101977NIGMS NIH HHS P41 GM103473NIGMS NIH HHS P41GM103473NIGMS NIH HHS P41 GM111244NIGMS NIH HHS R24 GM098791NIGMS NIH HHS T32 GM008271
6 · The paper itself

Abstract

Pore-forming toxins (PFTs) are a class of pathogen-secreted molecules that oligomerize to form transmembrane channels in cellular membranes. Determining the mechanism for how PFTs bind membranes is important in understanding their role in disease and for developing possible ways to block their action. Vibrio vulnificus, an aquatic pathogen responsible for severe food poisoning and septicemia in humans, secretes a PFT called V. vulnificus hemolysin (VVH), which contains a single C-terminal targeting domain predicted to resemble a β-trefoil lectin fold. In order to understand the selectivity of the lectin for glycan motifs, we expressed the isolated VVH β-trefoil domain and used glycan-chip screening to identify that VVH displays a preference for terminal galactosyl groups including N-acetyl-d-galactosamine and N-acetyl-d-lactosamine. The X-ray crystal structure of the VVH lectin domain solved to 2.0Å resolution reveals a heptameric ring arrangement similar to the oligomeric form of the related, but inactive, lectin from Vibrio cholerae cytolysin. Structures bound to glycerol, N-acetyl-d-galactosamine, and N-acetyl-d-lactosamine outline a common and versatile mode of recognition allowing VVH to target a wide variety of cell-surface ligands. Sequence analysis in light of our structural and functional data suggests that VVH may represent an earlier step in the evolution of Vibrio PFTs.

Indexed as

Evolution, MolecularAcetylgalactosamineAmino Acid SequenceAmino SugarsCalorimetryCell MembraneCrystallography, X-RayGlycerolHemolysin ProteinsHumansLectinsModels, MolecularMolecular Sequence DataPerforinPhylogenySequence Homology, Amino AcidAcetylgalactosamineAmino SugarsGlycerolHemolysin ProteinsLectinsN-acetyllactosaminePerforinbacterial pathogenesiscarbohydratecrystallographycytolysinpore-forming toxin

Identifiers

PMID24862282
PMCPMC4102649
OpenAlexW2094946661

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.